What is Sclerosing Mesenteritis

TL;DR: Sclerosing mesenteritis is a rare, chronic inflammatory condition characterized by the thickening and scarring (fibrosis) of the mesentery, the fold of tissue that attaches the intestines to the abdominal wall. While the exact cause remains unknown, it is considered a form of IgG4-related disease or a localized inflammatory reaction that can cause significant abdominal pain, bowel obstruction, and digestive distress.

What exactly happens in Sclerosing Mesenteritis?

In sclerosing mesenteritis, the fatty tissue of the mesentery becomes inflamed and eventually replaces normal tissue with fibrous, scar-like tissue. This process can be divided into three stages: mesenteric panniculitis (inflammation of the fat), retractile mesenteritis (contraction and scarring), and mesenteric lipodystrophy (atrophy of the fat). Because the mesentery carries blood vessels and nerves to the intestines, this scarring can compress these structures, leading to the clinical symptoms experienced by our 8 sclerosing mesenteritis community members on DiseaseMaps.org.

Who is most likely to develop Sclerosing Mesenteritis?

Sclerosing mesenteritis is a rare clinical entity, with estimates suggesting a prevalence of approximately 1 in 100,000 individuals, though this is likely underdiagnosed due to its non-specific symptoms. It is most frequently diagnosed in adults between the ages of 50 and 70, with men being affected roughly two to three times more often than women. While there is no known geographic "hotspot," the condition is increasingly recognized in patients with a history of abdominal surgery, trauma, or underlying autoimmune disorders.

What are the key clinical features and classifications?

The presentation of sclerosing mesenteritis varies widely, ranging from asymptomatic incidental findings on scans to severe, life-altering abdominal distress. Clinicians generally categorize the disease based on the predominant tissue change, but it is effectively a spectrum of the same inflammatory process. Common features that differentiate it from other inflammatory bowel conditions include:

• Chronic, persistent abdominal pain often localized in the mid-abdomen.


• Nausea, vomiting, or significant weight loss caused by partial bowel obstruction.


• A palpable abdominal mass in some patients.


• Distinctive "fat halo sign" or "misty mesentery" appearance on CT scans.


• Associated systemic conditions such as IgG4-related disease, retroperitoneal fibrosis, or certain malignancies.

Is Sclerosing Mesenteritis a form of cancer?

It is important to clarify that sclerosing mesenteritis is a benign, non-cancerous inflammatory condition. However, because its appearance on imaging can mimic certain tumors or lymphomas, diagnostic biopsy is often required to rule out malignancy definitively. Because it is a rare disease, the medical community emphasizes the importance of a multidisciplinary approach involving gastroenterologists, radiologists, and surgeons to ensure an accurate diagnosis.

Next steps

• Consult a gastroenterologist or a surgeon specializing in abdominal inflammatory conditions to discuss your specific imaging and symptoms.


• Request a referral to a center of excellence that has experience with rare mesenteric disorders or IgG4-related diseases.


• Join the sclerosing mesenteritis support group on DiseaseMaps.org to connect with others who are navigating similar diagnostic and treatment journeys.


• Keep a detailed symptom diary to help your physician track how sclerosing mesenteritis impacts your daily life and nutritional status.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Sclerosing Mesenteritis Overview.


• Orphanet: Rare Disease Database (ORPHA: 2470).


• National Library of Medicine (PubMed): Systematic reviews on the clinical management of mesenteric panniculitis.


• OMIM (Online Mendelian Inheritance in Man): Clinical data on fibro-inflammatory conditions.